Articles

Sustainability, artificial intelligence and economic considerations are hot topics at this year’s meeting

XLRP often leads to blindness by middle age with no treatment options currently available

Investigators say the discovery highlights the importance of genetic consultation

The mapping method revealed prominent microscopic abnormalities consistent with DR

Paying attention to high-resolution OCT is more important than ever

The NP-1/NP-1C preloaded IOL injector has already been made available in parts of Asia

Metabolomics reflects the physiological state of a tissue and provides information about interactions between genetics, environment and lifestyle

Simply slowing disease progression is no longer enough

ARVO attendees took a deep dive into trends and explored the near future of vision science

Study could influence screening protocols for neonatal patients

Investigators put forth a list of considerations for surgeons ahead of lens removalin paediatric patients

Plasma emission can act as a therapeutic for blepharitis, dry eye and other ocular disease

Investigators reported findings from the first study of successful macular hole closure using topical therapy

Investigators assessed the XEN45 implant alone and in combination with phacoemulsification

Early results indicate that trained optometrists delivered safe and effective laser treatments

The flagship, light-based technology has received approval for applications in the anterior and posterior segments

Surgeons shared practical pearls in a “Cataract Olympiad"

This year’s meeting will take place in Ireland’s technology and business hub

Three approaches to examination give a comprehensive overview

The approval also grants Outlook Therapeutics an initial 10 years of market exclusivity in the EU for bevacizumab gamma (LYTENAVA)

The light-based therapy functions using a virtual reality headset

Challenging choices force ophthalmologists to weigh long-term outcomes

Inhibiting ferroptosis could be crucial to reducing inflammation

Analysis of the OAKS and DERBY trials showed reduced growth rates of SD-OCT biomarkers for geographic atrophy

Professor Lois accepted the award at the Royal College of Ophthalmologists Annual Congress